Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

AstraZeneca hit by lung cancer drug setback: Pharma giant halts trials of experimental Volrustomig treatment

Astra said its Volrustomig treatment, when combined with chemotherapy, was unlikely to help lung cancer patients live longer than rival offerings.

AstraZeneca hit by lung cancer drug setback: Pharma giant halts trials of experimental Volrustomig treatment

We haven't written up this one. This Is Money has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at thisismoney.co.uk →

More in Health & Medicine

More from Monday 17 August →